[Effect of clarithromycin on prolonging the life expectancy of patients with primary lung cancer].
Mikasa
K
K
Sawaki
M
M
Kita
E
E
Hamada
K
K
Sakamoto
M
M
Konishi
M
M
Maeda
K
K
Teramoto
S
S
Tsujimoto
M
M
Mori
K
K
Ueda
K
K
Fukuoka
K
K
Segawa
K
K
Kataoka
T
T
Narita
N
N
D000230:Adenocarcinoma / Q000401:mortality / Q000628:therapy; D000328:Adult; D000368:Aged; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D018287:Carcinoma, Large Cell / Q000401:mortality / Q000628:therapy; D002294:Carcinoma, Squamous Cell / Q000401:mortality / Q000628:therapy; D017291:Clarithromycin / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D007155:Immunologic Factors / Q000627:therapeutic use*; D008175:Lung Neoplasms / Q000401:mortality / Q000628:therapy*; D008297:Male; D008875:Middle Aged; D015996:Survival Rate
D000900:Anti-Bacterial Agents; D007155:Immunologic Factors; D017291:Clarithromycin